Exosomes in Diabetic Wound Healing: Mechanisms, Applications, and Perspectives
Yi J., Tang Q., Sun S., Xie H., Wang L., Yin X.
Narrative Review on Diabetic Foot, Chronic Wound, published in Diabetes Metab Syndr Obes (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Diabetes Metab Syndr Obes (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40862233
- PMCID
- PMC12377389
- DOI
- 10.2147/dmso.s532885
- Citations
- 2
Abstract (original English)
Delayed wound healing is a major complication of diabetes, significantly impacting patients' quality of life. Traditional treatments, such as wound debridement, dressing application, and growth factor therapy, often suffer from limited efficacy and significant side effects. In recent years, exosomes have emerged as a promising therapeutic strategy for promoting diabetic skin wound healing. Exosomes, nano-sized vesicles secreted by cells, are rich in bioactive components, including proteins, nucleic acids, and lipids, enabling them to participate in intercellular communication and modulate cellular functions. Studies have demonstrated that exosomes derived from stem cells can significantly enhance diabetic wound healing. This effect is attributed to their ability to modulate key wound healing processes, including shortening the inflammatory phase, promoting angiogenesis, facilitating cell migration and re-epithelialization, and regulating collagen remodeling. Moreover, various pre-treatment strategies, applied to either the exosome-secreting cells or the isolated exosomes themselves, can significantly augment their therapeutic efficacy. As natural nanocarriers with low immunogenicity and high targeting specificity, exosomes hold great promise in tissue repair and regenerative medicine. This review summarizes the latest research progress on exosomes in diabetic wound healing, exp
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations